In various fields like health, environmental control, food security, and military defense, there is an increasing demand for on-site detection, fast identification, and urgent response which bring about the necessity to employ laboratory detection procedures on standalone automatic devices. In response to that, TUBITAK BILGEM's Bioelectronic Devices and Systems Group has been developing portable and fully automated biosensor devices using optical and electrochemical biosensor detection techniques. Here we describe a new integrated and fully automated lab-on-a-chip based biosensor device 'MiSens'. The key features of the MiSens include a new electrode array, an integrated microfluidic system, and real-time amperometric measurements during the flow of enzyme substrate. While simple protocols can be controlled from the LCD display on the device, other main device control procedures can be run wireless by a tablet/PC using the MiCont™ software developed by the team. For the device, a new plug and play type sensor chip docking station has been designed that with one move it enables the formation of a ~ 7-10 µL capacity flow cell on the electrode array with the necessary microfluidic and electronic connections. The MiSens device has been developed by our multi-disciplinary team by integrating and automatising the earlier developed sensing platform REP™ (Real-time Electrochemical Profiling). The performance of the MiSens device has been tested using cyclic voltammetry and amperometry tests and the results were compared with an of the shelf potentiostat.
INTRODUCTION
Biosensors are analytical devices that comprise a biological recognition element, a suitable transducer, and an appropriate data processing system (1) (2) (3) . While one of the main application of the biosensors are in the research and development for biomolecule interaction analysis or drug discovery, it is also possible to design biosensors for end users in order to perform analytical measurements for environmental monitoring, quality assurance in agriculture/food and medical diagnostics (4) . The number of biosensorrelated articles has exceeded 9000 / year; search on the term ''biosensor*'' for 2015 yields 9226 articles, using the Web of Knowledge, 8 times more than that of the year 2000. Compared with the numerous publications and patents available since the early 1990's, the commercialisation of the miniaturised biosensor devices for end users has significantly lagged behind the research output. (2, 5) . However, in recent years due to the advances in microelectronics, nanotechnology, bioengineering, and especially the microfluidic technologies, new on-site or point-of-care biosensor devices started to appear in the diagnostics market indicating a significant change (6) . Currently, testing for in vitro diagnostics is typically performed in centralised laboratories using large automated analysers in hospitals (7, 8) . Similarly, tests for environmental monitoring and quality control of food/agriculture products typically performed in centralised laboratories using expensive laboratory equipment and trained personnel (2, (9) (10) (11) (12) . To eliminate sample transportation, to reduce the time spent between the sample acquisition to the results and hence for a rapid response to an emergency, fully automated on-site testing devices are promising tools. Portable biosensor devices connected through the Internet of Things may change the way we perform the analytic measurements not only in healthcare but also for other application areas of the biosensors. Therefore, for on-site testing, a biosensing platform needs to be able to work automatically with minimum user interference. The tasks that need to be automated may include sample preparation, separation, detection, waste collection, and data analysis.
While it is reasonably easy to manipulate fluids using the bench top biosensor devices using automated pipetting and robotic arms, for portable devices that deals with microlitres or smaller amounts of liquids it constitutes a challenge. Recent advances in microfluidics have enabled the miniaturisation of the devices and multiplex testing of a range of analytes (13) (14) (15) . Advanced micro fabrication techniques have facilitated integration of sensing functionalities with microfluidics on the same biochip enabling automated systems (14) . To address the need in automated and on-site testing of analytes, a new electrochemical biosensor device has been developed by TUBITAK BILGEM that relies of Real-time Electrochemical Profiling (REP TM ) and novel electrode array based biochips. 
MATERIALS AND METHODS

Materials
Electrochemical Analysis
An integrated and fully automated electrochemical biosensor has been designed and 
Biochip Surface Modification
Surface modification of the SPE and MiSens biochips with a self-assembled monolayer (SAM) has been achieved by plasma cleaning of the arrays and later immersing in an ethanolic solution of 2 mM MUDA for overnight. Later, the electrode arrays were rinsed with ethanol and water. After drying with nitrogen stream, the arrays were vacuumpacked and stored at +4ºC till use.
Enzymatic Assay
For the MiSens assay, enzyme assays were performed by mixing HRP enzyme and TMB substrate, then injecting 150 µL of this solution to the biochip at 55 µL/min. The real-time 
RESULTS AND DISCUSSION
Device Integration
The MiSens device has been developed by TUBITAK BILGEM's multi-disciplinary team by integrating and automatising the earlier developed sensing platform REP TM (17) . 
Sensor Surface Characterization
To investigate the electrochemical behaviour of the designed electrode arrays, cyclic voltammetry technique has been utilised and voltammograms were recorded for a model electroactive species, potassium ferricyanide (19, 20) . Application of alkanethiols on a gold electrode surface forms a self-assembled monolayer and hence insulates the electrode surface (21, 22) . By comparing the cyclic voltammograms of a bare gold electrode and SAM coated gold electrode, it is possible to investigate the coverage of the monolayer. Cyclic voltammograms of bare Au and SAM coated MiSens biochip and SPE were obtained using K4[Fe(CN)6] as the electroactive marker. As it could be seen from the Figure 3A -C, the oxidation and reduction peaks of K4[Fe(CN)6] was visible and there was a larger redox area between positive and negative potential sweeps when cyclic voltammetry performed on bare gold surfaces. Whereas, the redox area between positive and negative potential sweeps of the SAM coated sensor chips were smaller in SPE, and non-existed in MiSens biochip. The SPE surface is formed using an ink containing Au and polymer, this surface shows a rough surface characteristic. While rough surface results in a larger electroactive area, the existence of polymer rather than pure Au results in lower coverage of SAM layer as seen from the cyclic voltammogram. However, MiSens biochips are made using pure Au that is sputtered on a flat glass slide. This surface is not as rough as the SPE, however as the electrode is formed using pure Au, the SAM coverage of the surface is higher as seen from the cyclic voltammogram ( Figure 3B ). For the HRP enzymatic activity measurement assays, initially plasma cleaned bare Au SPE and MiSens biochips were coated with a SAM layer. The Au surface of the electrodes were coated with a self assembled monolayer (MUDA) to prevent the adsorbance of HRP on the electrode array surface and also to mimick a recognition element (antibody, DNA etc) immobilised electrode, in other words an electrode with a reduced electrochemically active area. Later, the enzyme assays were performed by mixing varying concentrations of HRP with a fixed concentration of TMB reagent, then injecting to the flow cell containing electrode arrays for MiSens, or dropping the solution on to the SPE surface. Later the chronoamperometric responses obtained at -0.1 V potential has been analysed (See Figure 4) . In Figure 5 , the raw data obtained from the enzyme assay using Misens biochips and device is shown. In Figure 6 -A, the amperometric signals obtained from both SPE and MiSens biochip are compared. As seen from this figure, the results obtained from both SPE and MiSens biochips were comparable to each other with coefficient of determination of 1.0 and 0.98, respectively. Although similar amperometric results have been obtained from both sensor chips, as the electroactive area of both chips differ, a considerable difference was observed when current density is calculated. As MiSens biochips have 1 mm diameter with respect to 4 mm diameter of SPE chips, the current density of MiSens biochips are 14.4 times higher than the SPE (Figure 6 -B, Table 1 ). A) The amperometric response from the enzymatic reaction of HRP and TMB has been plotted with respect to HRP concentration for MiSens and SPE electrodes. B) The current response obtained from the chronoamperometry results after the addition of 25 ng/mL HRP and TMB reagent were used to assess the current density on MiSens biochip and Au SPE. *The area calculation does not take into account the roughness of the SPE chip. If that is also considered, the current density of the SPE chip will further decrease. The MiSens chip is produced by sputtering Au on a glass slide surface, hence its roughness is minimal with respect to the SPE chips.
The HRP and substrate reaction incubation time have direct effect to the detection limit of the assay and usually ranges from a few minutes to an hour. While in almost all studies minimum 15 minutes of HRP reaction time is allowed, in the current study the aim was to minimise the assay time since the biosensor device MiSens has been designed for on-site or point of care detection. As can be seen from Table 2 , even without any incubation, a detection limit of 3.4 × 10 -11 M has been achieved for the HRP enzyme activity using the MiSens biosensor device. Here, we have shown that MiSens device can be used as a flow injection analysis system for the detection of HRP enzymatic activity, hence an indication that it can be utilised as an electrochemical ELISA reader. In addition to that the easily programmable automated flow injection system of the device enables the injection of multiple analytes to the sensor surface in the required order hence immunoassays can be performed on the electrode surface directly with ease (26). format of the MiSens device and its microfluidic system enables electrochemical measurements to be performed with ease, hence provides a very effective tool for research and development of new biosensing assays. In the future, MiSens device has also a potential to be used for on-site testing of environmental / food toxins, and for biodefense.
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